GlassScriptPhysician profile
Paul M Joubert
NPI 1689666042
$1,168.01
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $918 · 2020: $203 · 2021: $28.92 · 2022: $17.49.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.22 | 2019-2020 | |
| Pfizer INC. | $152.05 | 2019-2022 | |
| Novo Nordisk INC | $139.52 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $115.12 | 2019 | |
| Lilly USA, LLC | $107.87 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.51 | 2019-2020 | |
| Amgen INC. | $55.72 | 2019 | |
| Glaxosmithkline, LLC. | $51.01 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $50.91 | 2019-2020 | |
| Astellas Pharma US INC | $49.54 | 2019 | |
| Abbvie INC. | $41.15 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $36.41 | 2019 | |
| Amarin Pharma, INC. | $26.67 | 2019 | |
| Antares Pharma, INC. | $23.60 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.33 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.49 | 2020 | |
| Boston Scientific Corporation | $12.44 | 2020 | |
| Sanofi Pasteur INC. | $12.30 | 2019 | |
| Genentech USA, INC. | $11.20 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $10.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Joubert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.